FDA approves first drug for full range of narcolepsy symptoms

The U.S. Food and Drug Administration has approved Orzeyful (oveporexton) tablets to treat narcolepsy type 1 in adults. Orzeyful marks the first medication approved for the full range of symptoms associated with narcolepsy ...

Night shift work linked to a higher risk of long COVID

The first evidence that night work and chronic insomnia may increase the risk of developing long COVID comes from a new study led by ISGlobal, a center supported by the "la Caixa" Foundation, in collaboration with the Germans ...

page 1 from 15